Resources

Filter by:

Filter by:

A largely random AAV integration profile after…

Abstract The clinical application of adeno-associated virus vectors (AAVs) is limited because of concerns...
View

AAVvector-mediated in vivo reprogramming into pluripotency

Abstract In vivo reprogramming of somatic cells into induced pluripotent stem cells (iPSC) holds...
View

An unbiased genome-wide analysis of zinc-finger nuclease…

Abstract Zinc-finger nucleases (ZFNs) allow gene editing in live cells by inducing a targeted...
View

Analyzing the Number of Common Integration Sites…

Abstract Vectors based on γ-retroviruses or lentiviruses have been shown to stably express therapeutical...
View

Bioinformatic clonality analysis of next-generation sequencing-derived viral…

Abstract Clonality analysis of viral vector-transduced cell populations represents a convincing approach to dissect...
View

Clonality analysis after retroviral-mediated gene transfer to…

Abstract A clinical trial of retroviral-mediated transfer of the adenosine deaminase (ADA) gene into...
View

Comprehensive genomic access to vector integration in…

Abstract Retroviral vectors have induced subtle clonal skewing in many gene therapy patients and...
View

Correction of X-linked chronic granulomatous disease by…

Abstract Gene transfer into hematopoietic stem cells has been used successfully for correcting lymphoid...
View
Load more

Meet the team

GeneWerk is led by renowned experts
in gene therapy safety assessment.

Meet the whole team

Dr. Irene Gil-Fariña

Head of Research and Development
View bio

Dr. Annette Deichmann

Managing Director
View bio

Dr. Manfred Schmidt (†)

CEO
View bio
Meet the whole team

Want to get in touch?

Consult with our experts about solutions to your biosafety challenges.

Get in touch
I agree to the Privacy Policy and Terms of Service.